US2016244531A1PendingUtilityA1
Method of increasing the effect of an activated-potentiated form of an antibody
Est. expiryJul 15, 2030(~4 yrs left)· nominal 20-yr term from priority
Inventors:Oleg Iliich Epshtein
A61P 43/00A61P 9/00A61P 9/12A61P 3/10A61P 9/10A61P 7/10A61P 25/24A61P 25/18A61P 25/22A61P 25/28A61P 1/08A61P 13/08A61P 1/00A61P 15/10A61P 25/00C07K 16/40A61K 41/0004A61K 9/20C07K 16/2869A61K 2039/507A61K 39/395C07K 16/18A61K 39/3955C07K 16/28
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The preset invention provides a method of increasing the effect of an activated-potentiated form of an antibody to an endogenous biological molecule by combining said endogenous biological molecule with an activated-potentiated form of an antibody to endothelial NO-synthase. The present invention also provides a pharmaceutical composition comprising a) an activated-potentiated form of an antibody to an endogenous biological molecule, and b) an activated-potentiated form of an antibody to NO synthase.
Claims
exact text as granted — not AI-modified1 . A method of increasing the effect of an activated-potentiated form of an antibody to an endogenous biological molecule, said method comprising combining a homeopathically potentized form of an antibody to an endogenous biological molecule with homeopathically potentiated form of an antibody to endothelial NO-synthase, the method further comprising administering said combination to a patient in need of treatment.
2 . (canceled)
3 . The method of claim 1 , wherein said homeopathically potentiated form of an antibody to an endogenous biological molecule is an antibody to S-100 protein.
4 . The method of claim 1 , wherein said homeopathically potentiated form of an antibody to an endogenous biological molecule is an antibody to prostate specific antigen.
5 . The method of claim 1 , wherein said homeopathically potentiated form an antibody to an endogenous biological molecule is an antibody to insulin receptor.
6 . The method of claim 1 , wherein said homeopathically potentiated form an antibody to an endogenous biological molecule is an antibody to angiotensin receptor.
7 .- 15 . (canceled)Join the waitlist — get patent alerts
Track US2016244531A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.